We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

First-of-Its-Kind Study Shows CAR-T Cell Therapy May Be Viable for Heart Disease Treatment

News   Sep 11, 2019 | By Molly Campbell, Science Writer, Technology Networks

 
First-of-Its-Kind Study Shows CAR-T Cell Therapy May Be Viable for Heart Disease Treatment
 
 
Advertisement
 

RELATED ARTICLES


Findings From Small Study Suggest COVID-19 Could Cause Changes in the Placenta

News

The placentas from 16 women who tested positive for COVID-19 while pregnant showed evidence of injury, according to pathological exams completed directly following birth, reports a new Northwestern Medicine study.

READ MORE

Converting Autoimmunity Drugs Into Powerful Anticancer Treatments

News

A team from the University of Southampton has discovered a way to transform antibody drugs previously developed to treat autoimmunity into antibodies with powerful anti-cancer activity through a simple molecular “switch”.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE